Xin Guo

Davis Polk & Wardwell / UNITED STATES


9

analized transaction

4875 Eur. ML

aggregated deals value

Last 12 months dossier

9

analized transaction

4875 Eur. ML

aggregated deals value

Full dossier

Client portfolio

PBV Rating


provides a qualitative rating based on Partner's clients feedback assessment

Communication Skills

The indicator measures the ability to convey information to another effectively and efficiently.

FusionCharts will load here.

Technical skills

The indicator measures knowledge of, and skill in the exercise of, practices required for successful accomplishment of a business, job, or task.

FusionCharts will load here.

Efficiency

The indicator measures the comparison of what is actually performed with what can be achieved with the same consumption of resources.

FusionCharts will load here.


Effectiveness

The indicator measures the degree to which objectives are achieved and the extent to which targeted problems are solved.

FusionCharts will load here.



Perceived Added Value

The indicator measures the evaluation of the difference between the cost of the tax / legal counsel and the contribution of the professional to achieve the business objectives of the matter.

FusionCharts will load here.

Market position

FusionCharts XT will load here!
FusionCharts XT will load here!

News

  • 8/20/2018
  • EN

    Bloom Energy Corporation's $270 Million Initial Public Offering

    Davis Polk advised the underwriters in connection with an initial public offering of 18,000,000 shares of common stock of Bloom Energy Corporation at $15.00 per share, for total gross proceeds of $270 million.
  • 8/15/2018
  • EN

    Palo Alto Networks, Inc. $1.5 Billion Convertible Senior Notes Offering

    Davis Polk advised the representatives of several initial purchasers in connection with a Rule 144A offering by Palo Alto Networks, Inc. of an aggregate principal amount of $1.5 billion of its 0.75% convertible senior notes due 2023.
  • 6/30/2018
  • EN

    Pandora Media, Inc.'s $193 Million Private Exchange Offers

    Davis Polk advised the sole placement agent in connection with the private exchange of an aggregate of approximately $193 million of Pandora Media, Inc.’s 1.75% convertible senior notes due 2020 for an equal principal amount of Pandora Media, Inc.’s 1.75% convertible senior notes due 2023 (the “new notes”).
  • 6/29/2018
  • EN

    Twitter's $1.15 Billion Convertible Notes Offering

    Wilson Sonsini Goodrich & Rosati represented Twitter in the offering
  • 5/18/2018
  • EN

    Unity Biotechnology's $85 Million Initial Public Offering

    Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 5,000,000 shares of common stock of Unity Biotechnology, Inc.
  • 4/16/2018
  • EN

    Pure Storage's $500 Million Convertible Senior Notes Offering

    Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Pure Storage, Inc. of $500 million aggregate principal amount of its 0.125% convertible senior notes due 2023.
  • 4/5/2018
  • EN

    Accelerate Diagnostics, Inc's $150 Million Convertible Senior Notes Offering

    Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount of its 2.50% convertible senior notes due 2023.
  • 3/19/2018
  • EN

    Atara Biotherapeutics, Inc. $302 Million Follow-On Offerings

    Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with two SEC-registered follow-on offerings of common stock of Atara Biotherapeutics, Inc., the first of which was for $140 million and closed on January 9, 2018, and the second of which was for $162 million and closed on March 5, 2018.
  • 2/12/2018
  • EN

    Seattle Genetics' $600 Million Equity Offering

    Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,269,230 shares of common stock, which includes 1,730,769 shares of common stock sold pursuant to the exercise of the underwriters’ over-allotment option.

Results are based upon public information and may undervalue a law firm's and/or a lawyer's professional experience and client portfolio.